---
figid: PMC6730558__nihms-1048375-f0004
figlink: /pmc/articles/PMC6730558/figure/F4/
number: Figure 4
caption: 'Zn2+-induced mitochondrial dysfunction is a critical and targetable early
  contributor to ischemic neuronal injury. During ischemia, Zn2+ accumulation in neurons
  reflects contributions from two primary sources: Zn2+ released from presynaptic
  vesicles that enters postsynaptic neurons (through Ca-AMPAR and voltage gated Ca2+
  channels [VGCC]), and Zn2+ released from MT-III (due to oxidative stress and acidosis)
  (1). This Zn2+ rapidly enters mitochondria through the mitochondrial Ca2+ uniporter
  (MCU) (2). An early consequence of mitochondrial Zn2+ accumulation is acute reactive
  oxygen species (ROS) generation, which can further disrupt cytosolic Zn2+ buffering,
  resulting in more mitochondrial Zn2+ entry and consequent dysfunction, thereby initiating
  a feedforward Zn2+-ROS cycle. (3). In addition, Zn2+ can induce delayed activation
  of NOX, producing more ROS, and possibly further amplifying this Zn2+-ROS cycle
  (4). This protracted Zn2+ influx into mitochondria triggers mitochondrial permeability
  transition pore (mPTP) opening, leading to mitochondrial depolarization, swelling,
  and cytochrome C release (5). These Zn2+ effects on mitochondria (ROS generation
  and mPTP opening) can activate major downstream events, including direct oxidative
  damage to proteins and DNA (that can lead to poly(ADP-ribose) polymerase [PARP]
  activation), activation of the apoptotic pathway via Caspase 3, and activation of
  p38 MAP (mitogen-activated protein) kinase, promoting the delayed insertionof Kv2.1
  K+ channels (6). Furthermore, cytosolic Zn2+, acting through incompletely defined
  mechanisms, can cause delayed insertion of Ca-AMPAR, further promoting delayed neurodegeneration
  (7). As these steps are temporally discrete, optimal therapeutic strategies will
  likely target a combination of them at different time points, as highlighted in
  timeline.'
pmcid: PMC6730558
papertitle: 'Mitochondrial Zn2+ Accumulation: A Potential Trigger of Hippocampal Ischemic
  Injury.'
reftext: Sung G. Ji, et al. Neuroscientist. 2019 Apr;25(2):126-138.
pmc_ranked_result_index: '212950'
pathway_score: 0.6033751
filename: nihms-1048375-f0004.jpg
figtitle: Zn2+-induced mitochondrial dysfunction is a critical and targetable early
  contributor to ischemic neuronal injury
year: '2019'
organisms: Homo sapiens
ndex: f057df07-df36-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6730558__nihms-1048375-f0004.html
  '@type': Dataset
  description: 'Zn2+-induced mitochondrial dysfunction is a critical and targetable
    early contributor to ischemic neuronal injury. During ischemia, Zn2+ accumulation
    in neurons reflects contributions from two primary sources: Zn2+ released from
    presynaptic vesicles that enters postsynaptic neurons (through Ca-AMPAR and voltage
    gated Ca2+ channels [VGCC]), and Zn2+ released from MT-III (due to oxidative stress
    and acidosis) (1). This Zn2+ rapidly enters mitochondria through the mitochondrial
    Ca2+ uniporter (MCU) (2). An early consequence of mitochondrial Zn2+ accumulation
    is acute reactive oxygen species (ROS) generation, which can further disrupt cytosolic
    Zn2+ buffering, resulting in more mitochondrial Zn2+ entry and consequent dysfunction,
    thereby initiating a feedforward Zn2+-ROS cycle. (3). In addition, Zn2+ can induce
    delayed activation of NOX, producing more ROS, and possibly further amplifying
    this Zn2+-ROS cycle (4). This protracted Zn2+ influx into mitochondria triggers
    mitochondrial permeability transition pore (mPTP) opening, leading to mitochondrial
    depolarization, swelling, and cytochrome C release (5). These Zn2+ effects on
    mitochondria (ROS generation and mPTP opening) can activate major downstream events,
    including direct oxidative damage to proteins and DNA (that can lead to poly(ADP-ribose)
    polymerase [PARP] activation), activation of the apoptotic pathway via Caspase
    3, and activation of p38 MAP (mitogen-activated protein) kinase, promoting the
    delayed insertionof Kv2.1 K+ channels (6). Furthermore, cytosolic Zn2+, acting
    through incompletely defined mechanisms, can cause delayed insertion of Ca-AMPAR,
    further promoting delayed neurodegeneration (7). As these steps are temporally
    discrete, optimal therapeutic strategies will likely target a combination of them
    at different time points, as highlighted in timeline.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - GRIN2D
  - MAPK14
  - GRIN3B
  - GRIN1
  - TNKS
  - GRIN2B
  - GRIN2C
  - CASP4
  - CASP6
  - CASP7
  - CASP8
  - CASP9
  - CASP10
  - KCNB1
  - MCU
  - GRIN3A
  - PARP4
  - GRIN2A
  - PARP14
  - PARP16
  - PARP6
  - PARP11
  - PARP12
  - MAPK11
  - MAPK13
  - MAPK12
  - PARP3
  - PARP2
  - PARP1
  - CASP12
  - CASP14
  - CASP1
  - CASP2
  - CASP3
  - PARP9
  - PARP10
  - PARP8
  - TNKS2
  - CA2
  - CASP5
  - PARP15
  - TIPARP
  - Glutamate
  - Zn
  - Ca
  - MPTP
  - Zn2
  - Ischemia
genes:
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2D
  entrez: '2906'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3B
  entrez: '116444'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN1
  entrez: '2902'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2B
  entrez: '2904'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2C
  entrez: '2905'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: Kv2.1
  symbol: Kv2.1
  source: hgnc_alias_symbol
  hgnc_symbol: KCNB1
  entrez: '3745'
- word: MCU
  symbol: MCU
  source: hgnc_symbol
  hgnc_symbol: MCU
  entrez: '90550'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN3A
  entrez: '116443'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: NMDAR
  symbol: NMDAR
  source: bioentities_symbol
  hgnc_symbol: GRIN2A
  entrez: '2903'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: p38
  symbol: p38
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: CaÂ²*
  symbol: CA-II
  source: hgnc_alias_symbol
  hgnc_symbol: CA2
  entrez: '760'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
chemicals:
- word: Glutamate
  source: ''
  identifier: ''
- word: Zn
  source: MESH
  identifier: D015032
- word: Ca
  source: MESH
  identifier: D002118
- word: MPTP
  source: MESH
  identifier: D015632
- word: Zn2
  source: MESH
  identifier: D015032
diseases:
- word: Ischemia
  source: MESH
  identifier: D007511
---
